(Q34291143)

1 August 2017

1 reference

title

Gentamicin dosing in critically ill patients (English)

1 reference

1 August 2017

0 references

Hansen M

1

1 reference

1 August 2017

Christrup LL

2

1 reference

1 August 2017

Jarløv JO

3

1 reference

1 August 2017

Kampmann JP

4

1 reference

1 August 2017

Bonde J

5

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 July 2001

1 reference

Acta Anaesthesiologica Scandinavica

1 August 2017

1 reference

1 August 2017

45

1 reference

1 August 2017

6

1 reference

1 August 2017

734-740

1 reference

Aminoglycosides: single or multiple daily dosing? A meta-analysis on efficacy and safety.

1 August 2017

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2001.045006734.X

Single or multiple daily doses of aminoglycosides: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2001.045006734.X

Once-daily aminoglycoside dosing in immunocompetent adults: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2001.045006734.X

A meta-analysis of studies on the safety and efficacy of aminoglycosides given either once daily or as divided doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2001.045006734.X

A meta-analysis of extended-interval dosing versus multiple daily dosing of aminoglycosides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2001.045006734.X

A meta-analysis of the relative efficacy and toxicity of single daily dosing versus multiple daily dosing of aminoglycosides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2001.045006734.X

Single daily dosing of aminoglycosides in immunocompromised adults: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2001.045006734.X

Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2001.045006734.X

Comparison of gentamicin dosing regimens using an in-vitro model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2001.045006734.X

Experience with a once-daily aminoglycoside program administered to 2,184 adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2001.045006734.X

Impact of altered aminoglycoside volume of distribution on the adequacy of a three milligram per kilogram loading dose. Critical Care Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2001.045006734.X

Once-daily aminoglycoside dosing assessed by MIC reversion time with Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2001.045006734.X

Gentamicin volume of distribution in critically ill septic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2001.045006734.X

Effectiveness and safety of once-daily aminoglycosides: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2001.045006734.X

7 January 2021

Impact of goal-oriented and model-based clinical pharmacokinetic dosing of aminoglycosides on clinical outcome: a cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2001.045006734.X

7 January 2021

Altered aminoglycoside pharmacokinetics in the critically ill

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2001.045006734.X

7 January 2021

Factors affecting gentamicin pharmacokinetics in septic patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2001.045006734.X

7 January 2021

Physiologic response of stress and aminoglycoside clearance in critically ill patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2001.045006734.X

7 January 2021

Positive impact of a therapeutic drug-monitoring program on total aminoglycoside dose and cost of hospitalization

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2001.045006734.X

7 January 2021

National survey of extended-interval aminoglycoside dosing

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-6576.2001.045006734.X

7 January 2021

10.1034/J.1399-6576.2001.045006734.X

Identifiers

DOI

1 reference

1 August 2017

1 reference